Compile Data Set for Download or QSAR
Report error Found 501 Enz. Inhib. hit(s) with all data for entry = 8372
TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243788(US9428456, 1.217)
Affinity DataEC50:  0.400nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243795(US9428456, 1.224)
Affinity DataEC50:  0.400nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243891(US9428456, 1.229)
Affinity DataEC50:  0.5nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243794(US9428456, 1.223)
Affinity DataEC50:  0.5nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243721(US9428456, 1.339)
Affinity DataEC50:  0.600nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243974(US9428456, 4.020)
Affinity DataEC50:  0.600nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243781(US9428456, 1.210)
Affinity DataEC50:  0.600nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243798(US9428456, 1.227)
Affinity DataEC50:  0.600nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243779(US9428456, 1.208)
Affinity DataEC50:  0.600nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243722(US9428456, 1.340)
Affinity DataEC50:  0.700nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243607(US9428456, 1.338)
Affinity DataEC50:  0.800nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243800(US9428456, 2.003)
Affinity DataEC50:  0.800nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243796(US9428456, 1.225)
Affinity DataEC50:  0.800nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243778(US9428456, 1.207)
Affinity DataEC50:  0.800nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243632(US9428456, 1.057)
Affinity DataEC50:  0.800nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243726(US9428456, 1.344)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243790(US9428456, 1.219)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243705(US9428456, 2.001)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243897(US9428456, 1.235)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243750(US9428456, 1.081)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243777(US9428456, 1.206)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243921(US9428456, 1.260)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243846(US9428456, 4.006)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243715(US9428456, 2.094)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243906(US9428456, 1.245)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243780(US9428456, 1.209)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243725(US9428456, 1.343)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243723(US9428456, 1.341)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243727(US9428456, 1.345)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243791(US9428456, 1.220)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243728(US9428456, 1.346)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243792(US9428456, 1.221)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243919(US9428456, 1.258)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243614(US9428456, 1.039)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243806(US9428456, 2.009)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243483(US9428456, 1.002)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243804(US9428456, 2.007)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243801(US9428456, 2.004)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243674(US9428456, 1.295)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243557(US9428456, 1.271)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243555(US9428456, 1.269)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243747(US9428456, 1.078)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243679(US9428456, 1.300)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243690(US9428456, 1.311)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243754(US9428456, 1.085)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243688(US9428456, 1.309)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243892(US9428456, 1.230)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243763(US9428456, 1.094)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243890(US9428456, 1.228)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM243636(US9428456, 1.061)
Affinity DataEC50:  1nMT: 2°CAssay Description:CHO-K1 CXCR7 b-arrestin cells are detached from culture dishes with a cell dissociation buffer (Invitrogen, #13151-014) and collected in growing medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
US Patent

Displayed 1 to 50 (of 501 total ) | Next | Last >>
Jump to: